Skip to search formSkip to main contentSkip to account menu

Immulite

Known as: Siemens Immulite 
A proprietary instrument for immunoassay analysis manufactured by Siemens.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Different prostate‐specific antigen assays give different results on the same blood sample: an obstacle to recommending uniform limits for prostate biopsies
To show the effect of different results for total prostate specific antigen (tPSA) and percentage free/total PSA (%fPSA) obtained… 
2007
2007
IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
2006
2006
Standardization of prostate-specific antigen (PSA) assays: can interchangeability of PSA measurements be improved?
The landscape of prostate cancer has changed since the appearance of the first prostate-specific antigen (PSA) assay. PSA testing… 
2004
2004
Development and validation of a third generation allergen-specific IgE assay on the continuous random access IMMULITE 2000 analyzer.
In vitro determination of allergen-specific IgE (sIgE) represents an important aid in the diagnosis and treatment of allergy… 
Highly Cited
2003
Highly Cited
2003
Evaluation of Two New Automated Assays for Hepatitis B Virus Surface Antigen (HBsAg) Detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg
ABSTRACT In recent years the diagnostic industry has developed new automated immunoassays for the qualitative detection of… 
2001
2001
Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer
Objective To assess the value of applying rigid threshold values in interpreting prostate specific antigen (PSA) results, by… 
1999
1999
Rapid detection of elevated prostate-specific antigen levels in blood: performance of various membrane strip tests compared.
Highly Cited
1997
Highly Cited
1997
Prostatic volume and ratio of free-to-total prostate specific antigen in patients with prostatic cancer or benign prostatic hyperplasia.
1996
1996
The periurethral glands do not significantly influence the serum prostate specific antigen concentration.
1996
1996
Clinical significance of the determination of noncomplexed prostate-specific antigen as a marker for prostate carcinoma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)